6 Recruiting Narcolepsy Type 1 Phase 2 Clinical Trials
Active phase 2 studies for narcolepsy type 1 enrolling across the USA. Verify eligibility and contact site coordinators.
All Narcolepsy Type 1 studiesPhase 2 Studies for Narcolepsy Type 1
🟢 Recruiting Phase2 / Phase3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
📍 Alkermes Investigational Site — Cullman, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
📍 Auburn, Alabama — Auburn, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
📍 Auburn, alabama — Auburn, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
📍 Colorado Springs, Colorado — Colorado Springs, Colorado
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
📍 Sleep Disorders Center of Alabama — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
📍 Takeda Site 12 — Redwood City, California
View Study & Checklist ➔